If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
6.00
Ask:
10.50
Spread: 4.50 (75.00%)
Market Cap: £2.73m
HYG Live PriceLast checked at - London Stock Exchange

Intraday Seneca Growth Share Chart

Directorate Change

9 Dec 2019 17:45



Directorate Change

Seneca Growth Capital VCT Plc (the “Company”)

9 December 2019

Appointment of Director

As envisaged in the Company’s Annual Report, which was published in April 2019, the Company has carried out a search for a further Non-Executive Director and is pleased to announce the appointment of Alex Clarkson to the Board and to the Audit Committee with effect from 9 December 2019.

Alex is a Managing Director of Bamburgh Capital. He qualified as a chartered accountant with PricewaterhouseCoopers in 1998, joined Brewin Dolphin Securities in 2000 before becoming co-founder of Zeus Capital in 2003. Alex then went on to co-found Bamburgh Capital in 2011, executing over 20 transactions acting on both the “buy” and “sell” side and raising funding. During this time, Alex was co-founder of Compass BioScience Group Limited and Collbio, two highly acquisitive companies, and became interim CFO of Collbio which undertook an IPO on the London Stock Market within an 18-month period, changing its name to Collagen Solutions.

Alex will stand for re-election by shareholders at the Annual General Meeting of the Company to be held in 2020. In relation to this appointment, there is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 R.

The Board now consists of four Directors comprising two Independent Directors who were appointed prior to the appointment of Seneca Partners Limited (‘the Manager’), Richard Manley, who is the representative of the Manager and Alex Clarkson, who is the third Independent Director. Notwithstanding that the Company is listed, it is one of the smallest by market value at present and is, therefore, not strictly subject to the recommendations of the Hampton-Alexander Report in respect of diversity. However, the Board fully supports the aims of that Report and intends to make further appointments to the Board in due course and will, over time, strive to comply with these recommendations.

For further information, please contact:

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk


Date   Source Headline
19th Mar 20085:02 pmRNSAnnual Report and Accounts
14th Jan 20085:22 pmRNSUpdate letter to Shareholders
3rd Jul 20063:56 pmRNSCompany Secretary Change
10th May 20062:49 pmRNSPurchase of Own Securities
26th Apr 20062:50 pmRNSChange of Name
25th Apr 20065:02 pmRNSDirector's Shareholding
20th Apr 20067:01 amRNSBVCT Update
20th Apr 20067:00 amRNSResult of AGM
10th Apr 20063:23 pmRNSDirector/PDMR Shareholding
3rd Apr 20064:28 pmRNSDirector's Shareholding
29th Mar 20061:09 pmRNSAnnual Information Update
24th Mar 20064:19 pmRNSFinal Results
9th Mar 20067:00 amRNSInvestment Process & Strategy
11th Nov 20054:33 pmRNSDirectorate Change
4th Nov 20054:04 pmRNSResult of AGM
3rd Oct 200511:19 amRNSNotice of AGM
27th Sep 20057:00 amRNSInterim Results
1st Sep 20058:31 amRNSBoard Changes
16th Aug 20055:51 pmRNSVCT Status
16th Aug 20059:09 amRNSVCT Status
2nd Aug 200510:56 amRNSBoard Change
12th Jul 20055:04 pmRNSBoard Changes
29th Apr 200510:22 amRNSFinal Results
14th Feb 20054:02 pmRNSIssue of Equity
9th Feb 20052:20 pmRNSCancellation of Listing
8th Feb 200511:27 amRNSCancellation of Listing
28th Jan 20052:55 pmRNSIssue of Equity
14th Jan 20053:40 pmRNSHolding(s) in Company
5th Jan 20054:32 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.